呼和浩特肛肠病好医院呼市屁眼处有肉出来,托克托县肛肠医院哪家比较好,呼市外痔费用价格,呼和浩特痔疮可以治疗吗,呼和浩特市治胃息肉医院那家,呼市哪医院治疗痔疮,呼和浩特早期肛裂的治疗方法

ABU DHABI, Jan. 16 (Xinhua) -- Visiting Chinese Premier Wen Jiabao held talks Monday with UN Secretary General Ban Ki-moon on major international issues.During their talks, Wen said the United Nations had played an indispensable role in boosting international cooperation and coordinated actions among related parties.China supports the UN and the Secretary General to play a bigger role in international affairs and achieve greater success, he said.Chinese Premier Wen Jiabao (L) meets with UN Secretary General Ban Ki-moon (R) in Abu Dhabi, the United Arab Emirates, Jan. 16, 2012.In promoting global sustainable development, the UN and the international community needed to focus on the elimination of poverty, help developing countries properly cope with the difficulties in their drive to transfer to a green economy and provide them with support in such areas as finance, technology and capacity building, Wen said.Ban said China had played an important role in helping attain the UN Millennium Development Goals (MDGs) and settle regional hot issues.Appreciating China's support for the UN, Ban said the United Nations stood ready to advance contacts with China and make concerted efforts to safeguard world peace and promote sustainable development.They also exchanged views on the situation of West Asia and North Africa and other regional issues of common concern.Wen arrived in the capital of the United Arab Emirates Monday morning after concluding an official visit to Saudi Arabia. He visited Nepal on Saturday before flying to the Middle East. The trip will also take him to Qatar.Earlier in the day, the Chinese premier gave a keynote speech at the opening of the 5th World Future Energy Summit.

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday revoked its approval of Avastin for treating the breast cancer after concluding that the drug has not been shown to be safe and effective for that use.Avastin will still remain on the market as an approved treatment for certain types of colon, lung, kidney and brain cancer."After reviewing the available studies it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," FDA Commissioner Margaret Hamburg said in a statement. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life. "Avastin's risks include severe high blood pressure; bleeding and hemorrhaging; heart attack or heart failure; and the development of perforations in different parts of the body such as the nose, stomach, and intestines.Avastin was approved for metastatic breast cancer in February 2008 under the FDA's accelerated approval program, which allows a drug to be approved based on data that are not sufficiently complete to permit full approval. After the approval, the drug's sponsor, Genentech, completed two additional clinical trials and submitted the data from those studies to the FDA. These data showed only a small effect on tumor growth without evidence that patients lived any longer or had a better quality of life compared to taking standard chemotherapy alone -- not enough to outweigh the risk of taking the drug.FDA's Center for Drug Evaluation and Research, which is responsible for the approval of this drug, ultimately concluded that the results of these additional studies did not justify continued approval and notified Genentech it was proposing to withdraw approval of the indication.Genentech did not agree with the Center's evaluation of the data and, following the procedures set out in FDA regulations, requested a hearing on the Center's withdrawal proposal, with a decision to be made by the Commissioner. That two-day hearing, which took place June 28-29, included recommendations from the FDA 's Oncologic Drugs Advisory Committee, voting 6-0 in favor of withdrawing approval of Avastin's breast cancer indication.

BEIJING, Jan. 1 (Xinhua) -- Chinese President Hu Jintao and his South Korean counterpart Lee Myung-bak exchanged new year greetings Sunday and announced the start of the "China-South Korea Friendly Exchange Year".In his message, Hu spoke positively of the relations between the two countries. Seizing the opportunity of the 20th anniversary of the establishment of the China-South Korea diplomatic relations, China is willing to work together with South Korea, by launching various exchange programs, to further promote mutual understanding and friendship between the two peoples, deepen communication and cooperation in all sectors, and push for constant progress of the bilateral relationship, Hu said.For his part, Lee said on the basis of the accomplishments achieved over the two decades of the bilateral diplomatic ties, South Korea looks forward to joining hands with China to build a better future for the bilateral relationship.

LOS ANGELES, Oct. 3 (Xinhua) -- An organizer of the World Stem Cell Summit says one of the key problems medical researchers face these days is how to apply their findings in the real world."How do you take the phenomenal scientific research going on in labs and translate it into medical treatments,?" said Bernie Siegel, the founder and co-chair of the summit and executive director of the Genetic Policy Institute, which organized the event."It's a big job to do this, and more than just the science," Siegel said, noting that in a growing field now moving beyond basic lab research, the aim is to connect the people who do the work with those who finance it.The three-day summit, which opened Monday in Pasadena, features more than 150 top international speakers and 50 hours of programming with leaders from science, pharmaceutics, business, policy, ethics, law and other fields.The cell therapy industry, a "nascent" field, has emerged to be a potentially multi-billion business with unlimited potential, Siegel said.Stephen Dalton, a University of Georgia professor, reported that one of the biggest developments in stem cell research in the past year was the realization that cells can be transdifferentiated from one state to another without returning to a pluripotent state.Dalton said the principle was previously supported by a few isolated examples but it was not until 2010 that the idea was widely accepted.Mark Sussman, a professor from San Diego State University, called the identification of lung stem cells from human tissue samples capable of regenerating the highly complex and specialized structures of mature lungs a breakthrough in lung biology and regenerative medicine.He said results presented by the Anversa group in the New England Journal of Medicine demonstrate that human lung stem cells can be expanded in vitro and also retain the capacity to integrate into adult tissue upon introduction into mice.The study, Sussman said, has opened up an entirely new field of possibilities for lung regeneration and potential therapeutic applications for many conditions where treatment options are either very limited or nonexistent.

BEIJING, Dec. 16 (Xinhua) -- Trade volume between China and the Association of Southeast Asian Nations (ASEAN) in 2010 was 36 times what it was in 1991, the year in which formal relations between the two sides were established, according to new statistics.The volume is expected to reach 500 billion U.S. dollars in 2015, according to figures revealed Friday at the China-ASEAN Beijing Economic Forum, an event taking place in China's capital from Dec. 16 to 18 to commemorate the 20th anniversary of the China-ASEAN relations.Ma Mingqiang, secretary-general of ASEAN-China Center, said China-ASEAN trade volume totaled 267 billion U.S. dollars in the first three quarters of 2011 and is expected to hit the annual target of 350 billion dollars this year.He said the two parties have become closely linked in the past two decades, as China is now ASEAN's largest trade partner while ASEAN ranks the third among China's trade partners.With the comprehensive implementation of the China-ASEAN Free Trade Agreement in 2010, China has made 90 percent of commodities traded between China and ASEAN countries free of tariffs.China and ASEAN have enjoyed rapid social and economic growth since they established bilateral cooperation, said Surin Pitsuwan, ASEAN secretary-general.ASEAN can provide human resources, natural resources and raw materials for China's industrial development, and it in turn wants to win more investment from China, said Pitsuwan.He said the cooperation not only is a win-win solution for both sides, but will also make a positive contribution to the world.Guo Jinlong, mayor of Beijing, said the city saw a 21.5 percent year-on-year increase in trade volume with ASEAN in 2010, and will further strengthen its cooperation with the countries.ASEAN groups Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam.